Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocol

Natasha Biscoe, Amanda Bonson, Max Slavin, Walter Busuttil, Deirdre MacManus, Andrew T. Cox, Dominic Murphy

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (71)

  1. Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity. 2023-12-20 · Expand citations
  2. Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD. 2023-05-04 · Expand citations
  3. Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. 2022-10-01 · Expand citations
  4. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. 2022-02-01 · Expand citations
  5. Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. 2021-11-08 · Expand citations
  6. Psilocybin and MDMA for the treatment of trauma-related psychopathology. 2021-05-01 · Expand citations
  7. Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study". 2021-01-01 · Expand citations
  8. The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology. 2021-01-01 · Expand citations
  9. Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study. 2020-10-01 · Expand citations
  10. Psychiatry & the psychedelic drugs. Past, present & future. 2018-11-01 · Expand citations
  11. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. 2018-02-01 · Expand citations
  12. Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults. 2017-12-01 · Expand citations
  13. Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression 2017-06-19 · Expand citations
  14. Long-term follow-up of psilocybin-facilitated smoking cessation. 2017-01-01 · Expand citations
  15. Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression. 2017-01-01 · Expand citations
  16. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  17. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
  18. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. 2016-12-01 · Expand citations
  19. The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. 2016-12-01 · Expand citations
  20. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. 2016-07-01 · Expand citations
  21. Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers. 2015-10-15 · Expand citations
  22. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. 2015-03-01 · Expand citations
  23. Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning. 2013-08-01 · Expand citations
  24. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. 2012-02-07 · Expand citations
  25. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
  26. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. 2006-11-01 · Expand citations
  27. Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man 1997-06-01 · Expand citations
  28. [Psilocybin, a psychotropic substance from the Mexican mushroom Psilicybe mexicana Heim]. 1958-03-15 · Expand citations
  29. OpenAlex W1514491136
  30. OpenAlex W1592541845
  31. OpenAlex W1899223624
  32. OpenAlex W1984534015
  33. OpenAlex W1985329916
  34. OpenAlex W2034106456
  35. OpenAlex W2037020348
  36. OpenAlex W2043705607
  37. OpenAlex W2053015387
  38. OpenAlex W2067271431
  39. OpenAlex W2110608362
  40. OpenAlex W2117207767
  41. OpenAlex W2148083007
  42. OpenAlex W2183110699
  43. OpenAlex W2271932166
  44. OpenAlex W2420933235
  45. OpenAlex W2725596576
  46. OpenAlex W2768866371
  47. OpenAlex W2769510074
  48. OpenAlex W2883003988
  49. OpenAlex W2884859892
  50. OpenAlex W2892364332
  51. OpenAlex W2895867878
  52. OpenAlex W2897508326
  53. OpenAlex W2967952821
  54. OpenAlex W2969621865
  55. OpenAlex W2992322507
  56. OpenAlex W3112173414
  57. OpenAlex W3133450788
  58. OpenAlex W3166611932
  59. OpenAlex W4211150788
  60. OpenAlex W4211211437
  61. OpenAlex W4212983967
  62. OpenAlex W4221122863
  63. OpenAlex W4224257950
  64. OpenAlex W4283814245
  65. OpenAlex W4304588955
  66. OpenAlex W6637985026
  67. OpenAlex W6717743309
  68. OpenAlex W6721119230
  69. OpenAlex W6832126151
  70. OpenAlex W6845689269
  71. OpenAlex W6850777613

Cited by — these papers cite this paper (2)

  1. Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping review 2026-07-26 · Expand citations
  2. BROAD SPECTRUM OF THERAPEUTIC PROPERTIES OF PSILOCYBIN: A LITERATURE REVIEW 2025-02-20 · Expand citations